<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1431">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01836900</url>
  </required_header>
  <id_info>
    <org_study_id>STING</org_study_id>
    <nct_id>NCT01836900</nct_id>
  </id_info>
  <brief_title>Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy</brief_title>
  <acronym>STING</acronym>
  <official_title>Endoscopic Treatment of Recurrent Upper GI Bleeding From Gastroduodenal Ulcers: OTSC [Over the Scope Clip] Versus Standard Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kliniken Ludwigsburg-Bietigheim gGmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Augsburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Marienkrankenhaus Frankfurt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Hanau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Garmisch-Patenkirchen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universit√§tsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kliniken Ludwigsburg-Bietigheim gGmbH</source>
  <oversight_info>
    <authority>Ethics comission Stuttgart, Germany:</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective-randomized trial. Patients with recurrent bleeding from gastroduodenal ulcers
      are randomized into either endoscopic treatment with the OTSC [Over The Scope Clip]  or
      endoscopic standard therapy. Hypothesis: Endoscopic therapy with OTSC is superior to
      standard therapy regarding technical success and rebleeding.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Persistent bleeding or Rebleeding with 7 days</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood units transfused</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of hospital stay</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of intensive care unit stay</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 d Mortality</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of endoscopic reinterventions</measure>
    <time_frame>7 d</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necessity of surgical or angiographic therapy</measure>
    <time_frame>7 d</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications during or after OTSC (Over The Scope Clip) placement</measure>
    <time_frame>7 d</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Acute Upper Gastrointestinal Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Standard Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endoscopic therapy with Standard Clip + injection of epinephrine solution or thermal therapy + injection of epinephrin-solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OTSC (Over The Scope Clip)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endoscopic therapy with Application of OTSC Clip and Injection of epinephrin-solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endoscopic hemostasis</intervention_name>
    <description>Hemostasis with Standard Therapy (standard clip or thermal therapy + injection of adrenaline solution) or by application of the Over The Scope Clip and injection of adrenaline solution</description>
    <arm_group_label>Standard Therapy</arm_group_label>
    <arm_group_label>OTSC (Over The Scope Clip)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recurrence of bleeding from gastroduodenal ulcers

        Exclusion Criteria:

          -  Malignant ulcers, variceal bleeding, patients younger than 18 years, lesions not
             suitable for treatment with OTSC
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Karel Caca, Prof. Dr.</last_name>
    <phone>+49714167201</phone>
    <email>karel.caca@kliniken-lb.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arthur Schmidt, Dr.</last_name>
    <phone>+49714167201</phone>
    <email>arthur.schmidt@kliniken-lb.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg</name>
      <address>
        <city>Ludwigsburg</city>
        <zip>71640</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arthur Schmidt, Dr</last_name>
      <phone>+49714167201</phone>
      <email>arthur.schmidt@klinken-lb.de</email>
    </contact>
    <contact_backup>
      <last_name>Katja Hahmann-Dolle, Dr.</last_name>
      <phone>+49714167201</phone>
      <email>katja.hahmann-dolle@klinken-lb.de</email>
    </contact_backup>
    <investigator>
      <last_name>Arthur Schmidt, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 17, 2013</lastchanged_date>
  <firstreceived_date>April 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OTSC</keyword>
  <keyword>Upper gastrointestinal bleeding</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
